Acta Scientific Otolaryngology (ASOL) (ISSN: 2582-5550)

Research Article Volume 3 Issue 6

Ethanol Inhalation for Disinfection of the Respiratory Tract Contaminated with Sars-Cov-2/Covid 19 in Positive Asymptomatic Subjects. Rationale and Proposal

Pietro Salvatori1*, Steven W Stogner2 and Yasuharu Tokuda3

1Independent Head and Neck Surgeon, Milan, Italy
2Consultant Pneumologist, Forrest General Hospital, Hattiesburg, MS, USA
3Director, Muribushi Okinawa Centre for Teaching Hospitals, Okinawa, Japan

*Corresponding Author: Pietro Salvatori, Independent Head and Neck Surgeon, Milan, Italy.

Received: May 15, 2021; Published: May 28, 2021

Abstract

Introduction: SARS-CoV-2 pandemic is a major health concern and is heavily affecting the social and economic lives. Similarly, to other highly contagious diseases, it is of outmost importance to early identify and treat the healthy carriers (asymptomatic positive subjects). SARS-CoV-2 entry points are mainly localised in the respiratory tract. Unfortunately, no specific virucidal treatments against SARS-CoV-2 are currently available. Monoclonal antibodies are under evaluation, but high cost and possible ineffectiveness against virus variants could limit its broad use. However, the problem could be approached by resorting nonspecific drugs. Among them, ethanol (ethyl alcohol) is known to be a powerful, cost-effective and abundant virucidal agent, now advised for surgical hand and surfaces disinfection.

Objectives: To determine the potential role of inhaled ethanol to disinfect SARS-CoV-2 positive asymptomatic subjects after having evaluated the dimension of the problem, ethanol efficiency and other beneficial effects on the respiratory tract, ethanol local and general toxicity and ethanol therapeutic window. Finally, to set up a study in order to verify the hypothesis.

Materials and Methods: Together with the consolidated knowledge, an extensive review of the medical literature has been carried out looking for sound data able to support (or discard) the rationale on which a study could be built up.

Results and Discussion: Evident data supporting the inhaled ethanol potential role on SARS-CoV-2 positive asymptomatic subjects disinfection have been found and discussed.

Conclusion: A clinical trial to test the hypothesis that inhaled ethanol could be rapidly efficient in lowering or eradicating SARS-CoV-2 from the respiratory tract in asymptomatic positive subjects is strongly advisable. Individual and public health benefits are stressed, together with economic and social positive fallouts.

Keywords: SARS-CoV-2; Covid-19; Ethanol; Inhalation; Public Health

References

  1. Sungnak W., et al. “SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes”. Nature Medicine 26 (2020): 681-687.
  2. Samuel B Polak., et al. “A Systematic review of pathological Findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression”. Modern Pathology 33 (2020): 2128-2138.
  3. Shiyi Cao., et al. “Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China”. Nature Communications 11 (2020): 5917.
  4. Eric J Nelson., et al. “SARS-CoV-2 Positivity on or After 9 Days Among Quarantined Student Contacts of Confirmed Cases”. The Journal of the American Medical Association (2021).
  5. Luigi Atripaldi., et al. “Could asymptomatic carriers spread the SARS-CoV-2 infection? Experience from the Italian second wave”. Journal of Translational Medicine 19 (2021): 93.
  6. Liu J., et al. “The duration of SARS-CoV-2 positive in the environments of quarantine rooms: a perspective analysis”. International Journal of Infectious Diseases (2021).
  7. https://www.worldometers.info/coronavirus/
  8. Oyungerel Byambasuren., et al. “Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis”. JAMMI4 (2020): 223-234.
  9. Chao Yu., et al. “Characteristics of asymptomatic COVID-19 infection and progression: A multicenter retrospective study Virulence 1 (2020): 1006-1014.
  10. Muge Cevik., et al. “SARS- CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis”. The Lancet (2020).
  11. M Bongiovanni., et al. “Natural history of SARS-CoV-2 infection in healthcare workers in Northern Italy”. Journal of Hospital Infection 106 (2020): 709e712.
  12. Patricia J Garcia., et al. “Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial”. Trials 1 (2021): 262.
  13. Chen RE., et al. “Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies”. Nature Medicine (2021).
  14. Jeremy Guenezan., et al. “Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial”. JAMA Otolaryngology – Head and Neck Surgery (2021).
  15. Ajay Kumar Mishra., et al. “Reporting of all cardiac medications and their outcome in COVID – 19”. Journal of Medical Virology (2020).
  16. Kampf G. “Efficacy of ethanol against viruses in hand disinfection”. Journal of Hospital Infection4 (2018): 331-338.
  17. Hossein Eslami., et al. “How Alcoholic Disinfectants Affect Coronavirus Model Membranes: Membrane Fluidity, Permeability, and Disintegration”. The Journal of Physical Chemistry B46 (2020): 10374-10385.
  18. Kampf G., et al. “Persistence of coronaviruses on inanimate surfaces and their inactvation with biocidal agents”. Journal of Hospital Infection3 (2020): 246-251.
  19. Annika Kratzel., et al. “Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO- Recommended Hand Rub Formulations and Alcohols”. Emerging Infectious Diseases7 (2020): 1592-1595.
  20. Thomas J Manning., et al. “Should ethanol be considered a treatment for COVID-19?” Revista da Associacao Medica Brasileira9 (2020).
  21. Joseph H Sisson., et al. “Alcohol stimulates ciliary motility of isolated airway axonemes through a nitric oxide, cyclase and cyclic nucleotide- dependent kinase mechanism”. Alcoholism: Clinical and Experimental Research4 (2009): 610-616.
  22. Simet SM., et al. “Dietary antoxidants prevent alcohol-induced ciliary dysfunction”. Alcohol 47 (2013A): 629-635.
  23. Abraham Gootnick., et al. “Inhalation of ethyl alcohol for pulmonary edema”. New England Journal of Medicine 245 (1951): 842-843.
  24. Aldo A Luisada., et al. “Treatment of pulmonary edema". The Journal of the American Medical Association154 (1954): 62.
  25. Calesnick B and Vernick HQ. “Antitussive actvity of ethanol”. Journal of Studies on Alcohol and Drugs2 (1971): 434-441.
  26. Burnham PJQ. “A new rapid treatment for the useless cough in the postoperative patient”. Northwestern University Medical School1 (1954): 76-78.
  27. https://www.sps.nhs.uk/artcles/ethanol-content-of-inhalers-what-is-the-signifcance/
  28. Sasanami M., et al. “Oral Ethanol Treatment for Ethylene Glycol Intoxication”. Cureus12 (2020): e12268.
  29. Sulaiman I., et al. “Microbial signatures in the lower airways of mechanically ventilated COVID19 patients associated with poor clinical outcome”. Med Rxiv (2021).
  30. Martina Rueca., et al. “Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing”. International Journal of Environmental Research and Public Health 18 (2021): 2174.
  31. Robert Ross MacLean., et al. “Inhalation of Alcohol Vapor: Measurement and Implications”. Alcoholism: Clinical and Experimental Research2 (2017): 238-250.
  32. Vincent Bessonneau and Olivier Thomas. “Assessment of Exposure to Alcohol Vapor from Alcohol- Based Hand Rubs”. International Journal of Environmental Research and Public Health3 (2012): 868-879.
  33. Boyce JM and Pitet D. “Guideline for hand hygiene in health-care settings”. American Journal of Infection Control 30 (2002): 1-46.
  34. Sharlee L More., et al. “PBPK modeling characterization of potential acute impairment effects from inhalation of ethanol during e-cigarete use”. Inhalation Toxicology1 (2020): 14-23.
  35. https://clinicaltrials.gov/ct2/show/NCT04554433
  36. https://www.clinicaltrialsregister.eu/ctr-search/search?query=2020-001760-29
  37. Castro-Balado A., et al. “Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early- Stage SARS-CoV-2 Infection”. Pharmaceutics 13 (2021): 342.
  38. Lorraine F H Irvine. “Relevance of the developmental toxicity of ethanol in the occupational setting: a review”. Journal of Applied Toxicology5 (2003): 289-299.
  39. Ruth J Bevan., et al. “An assessment of potential cancer risk following occupational exposure to ethanol”. Journal of Toxicology and Environmental Health, Part B3 (2009): 188-205.
  40. Samantha M Yeligar., et al. “Alcohol and Lung Injury and Immunity”. Alcohol 55 (2016): 51-59.
  41. Winek CL and Murphy KL. “The rate and kinetic order of ethanol elimination”. Forensic Science International3 (1984): 159-166.
  42. Dasha Majra., et al. “SARS-CoV-2 (COVID-19) superspreader events”. Journal of Infection1 (2021): 36-40.
  43. M Szmigiera. “Impact of the coronavirus pandemic on the global economy - Statistics and Facts (2021).
  44. M Eterpi and G McDonnell V. “Thomas Decontamination efficacy against Mycoplasma”. Letters in Applied Microbiology2 (2011): 150-155.
  45. Mat O Ruuskanen., et al. “Links between gut microbiome composition and fatty liver disease in a large populaton sample”. Gut Microbes1 (2021): e1888673.
  46. Seo SO., et al. “A comparative phenotypic and genomic analysis of Clostridium beijerinckii mutant with enhanced solvent production”. Journal of Biotechnology 329 (2021): 49-55.
  47. Tsumoru Shintake. “Possibility of Disinfection of SARS-CoV-2 (COVID-19) in Human Respiratory Tract by Controlled Ethanol Vapor Inhalation”. Ar Xiv (2003): 12444v1.

Citation

Citation: Pietro Salvatori.,et al. “Ethanol Inhalation for Disinfection of the Respiratory Tract Contaminated with Sars-Cov-2/Covid 19 in Positive Asymptomatic Subjects. Rationale and Proposal".Acta Scientific Otolaryngology 3.6 (2020): 126-134.

Copyright

Copyright: © 2020 Pietro Salvatori.,et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate34%
Acceptance to publication20-30 days
Impact Factor0.871

Indexed In








News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 30, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US